Physician profile
James Kim
NPI 1821373473
$3,224.26
in general payments reported to CMS, 2019-2025
21 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $104 · 2021: $217 · 2022: $420 · 2023: $803 · 2024: $1,058 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,797 · Entertainment: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,796.74 |
| Entertainment | $460.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $643.35 | 2019-2024 | Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $572.38 | 2022-2025 | Infuse, Miebo, Xiidra |
| Optos, INC. | $460.57 | 2024-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $242.82 | 2022-2024 | |
| Johnson & Johnson Vision Care, INC. | $197.41 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $158.90 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $119.12 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $115.60 | 2024 | |
| Sight Sciences, INC. | $112.00 | 2022 | |
| Rxsight INC | $111.21 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $83.65 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $79.53 | 2021-2023 | |
| Coopervision INC. | $72.83 | 2023 | Myday Contact Lens |
| Dompe US, INC. | $63.13 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $56.61 | 2022-2023 | Tyrvaya |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $30.31 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $30.00 | 2024 | Spectacle Lenses, Contact Lens |
| Allergan, INC. | $27.76 | 2021-2022 | |
| Thea Pharma INC. | $18.53 | 2024 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $14.30 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.